0001127602-19-034132.txt : 20191203
0001127602-19-034132.hdr.sgml : 20191203
20191203162530
ACCESSION NUMBER: 0001127602-19-034132
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191202
FILED AS OF DATE: 20191203
DATE AS OF CHANGE: 20191203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WHITE ROBERT JOHN
CENTRAL INDEX KEY: 0001726709
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36820
FILM NUMBER: 191266068
MAIL ADDRESS:
STREET 1: MEDTRONIC PLC
STREET 2: 710 MEDTRONIC PKWY MS LC300
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55432
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Medtronic plc
CENTRAL INDEX KEY: 0001613103
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 000000000
FISCAL YEAR END: 0424
BUSINESS ADDRESS:
STREET 1: 20 ON HATCH, LOWER HATCH STREET
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: 01135314381700
MAIL ADDRESS:
STREET 1: 20 ON HATCH, LOWER HATCH STREET
CITY: DUBLIN
STATE: L2
ZIP: 2
FORMER COMPANY:
FORMER CONFORMED NAME: Medtronic Ltd
DATE OF NAME CHANGE: 20150112
FORMER COMPANY:
FORMER CONFORMED NAME: Medtronic Holdings Ltd
DATE OF NAME CHANGE: 20140711
FORMER COMPANY:
FORMER CONFORMED NAME: Kalani I Ltd
DATE OF NAME CHANGE: 20140709
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2019-12-02
0001613103
Medtronic plc
MDT
0001726709
WHITE ROBERT JOHN
MEDTRONIC PLC
710 MEDTRONIC PKWY MS LC300
MINNEAPOLIS
MN
55432
1
EVP & President MITG
Ordinary Shares
2019-12-02
4
M
0
25442
47.00
A
77510
D
Ordinary Shares
2019-12-02
4
M
0
26724
74.84
A
104234
D
Ordinary Shares
2019-12-02
4
S
0
13484
110.285
D
90750
D
Ordinary Shares
2019-12-02
4
S
0
13240
110.973
D
77510
D
Ordinary Shares
2019-12-02
4
S
0
12859
110.28
D
64651
D
Ordinary Shares
2019-12-02
4
S
0
12583
110.973
D
52068
D
Stock Option (Right to Buy)
47.00
2019-12-02
4
M
0
25442
0
D
2014-12-02
2023-12-01
Ordinary Shares
25442
0
D
Stock Option (Right to Buy)
74.84
2019-12-02
4
M
0
26724
0
D
2018-06-29
2025-01-27
Ordinary Shares
26724
0
D
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.72 to $110.70, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.73 to $111.51, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.73 to $110.72, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.76 to $111.54, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Perry F. Sekus, attorney-in-fact
2019-12-03